(Q42928477)

11 November 2017

title

Risk of arterial thrombosis not increased by sorafenib or sunitinib (English)

1 reference

11 November 2017

Risk of Arterial Thrombosis Not Increased by Sorafenib or Sunitinib (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.0219

21 June 2024

1 reference

David R. Minor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20733133

21 June 2024

language of work or name

English

0 references

publication date

23 August 2010

1 reference

full work available at URL

11 November 2017

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.31.0219?role=tab

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20733133

http://intl.jco.org/cgi/content/abstract/28/30/e619

21 June 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20733133

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.31.0219

21 June 2024

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.0219

Journal of Clinical Oncology

21 June 2024

published in

1 reference

11 November 2017

volume

28

1 reference

11 November 2017

issue

30

1 reference

11 November 2017

page(s)

e619; author reply e620

1 reference

Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.0219

Sorafenib in advanced clear-cell renal-cell carcinoma

21 June 2024

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.0219

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

21 June 2024

3

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.0219

Risk of bleeding not increased by sorafenib or sunitinib

21 June 2024

4

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.0219

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

21 June 2024

6

1 reference

https://api.crossref.org/works/10.1200/JCO.2010.31.0219

21 June 2024

Identifiers

1 reference

11 November 2017

1 reference